Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes, you can ask your doctor about weight loss medications, but approval requires meeting specific clinical criteria. The FDA approves weight loss drugs primarily for individuals with a BMI of 30 or higher, or BMI of 27 with weight-related comorbidities like hypertension or type 2 diabetes.

Understanding your medical eligibility involves more than BMI alone. Biomarkers, metabolic health, family history, and individual genetic predispositions in peptide pathways may provide context that supports a more informed conversation with your healthcare provider about personalized weight management options.

Medical Criteria Your Doctor Will Evaluate

Your doctor will assess eligibility based on established clinical guidelines. Weight loss medications are typically recommended for adults with BMI ≥30, or BMI ≥27 with weight-related conditions. Contraindications include personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or severe kidney disease.

Beyond BMI, your provider will review metabolic markers, current medications, cardiovascular health, and whether previous weight loss attempts have been unsuccessful. This comprehensive evaluation ensures the medication is appropriate for your specific health profile and minimizes potential risks.

Biomarkers and Metabolic Factors in Treatment Selection

Several biomarkers can inform whether peptide-based weight management may be relevant to your health situation. Fasting glucose, HbA1c, lipid panels, inflammatory markers, and insulin resistance indicators provide your provider with a fuller picture of your metabolic health beyond weight alone.

Biomarker Normal Range Relevance to Weight Management
Fasting Glucose <100 mg/dL Elevated levels may indicate insulin resistance, which peptide therapies may address
HbA1c <5.7% Prediabetic range (5.7-6.4%) strengthens case for GLP-1 class medications
Triglycerides <150 mg/dL High levels often correlate with metabolic dysfunction and weight gain patterns
Lipid Panel (HDL) >40 mg/dL (men) Low HDL is cardiovascular risk factor that weight loss medications may improve

How Genetic Predisposition May Inform Your Conversation

Emerging research in peptide pathway genetics reveals that certain variants in genes like GLP1R, GIPR, FTO, and MC4R may predispose individuals to differential responses in appetite regulation and weight management. These genetic insights do not predict exact medication response, but may provide context for your provider.

A genetic assessment can help identify whether your body's peptide signaling pathways show predispositions that align with how certain weight management approaches work. This information may support a more personalized discussion with your provider about which treatment options warrant consideration in your specific case.

Understanding Your Options and Having the Conversation

When speaking with your doctor, come prepared with your weight history, previous diet and exercise attempts, current medications, and any weight-related health conditions. Mention if you have family history of obesity, diabetes, or metabolic disease—this context strengthens the clinical case for medication consideration.

Your provider may recommend branded medications, compounded formulations, or combination approaches depending on cost, supply, and your specific health profile. Discuss both benefits and potential side effects, including gastrointestinal symptoms, rare but serious risks, and the need for ongoing monitoring during treatment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context by revealing predispositions in your GLP1R, GIPR, FTO, and MC4R genetic pathways. These insights do not predict medication response, but can support a more informed discussion with your provider about whether peptide-based therapies align with your individual biology.

The genetic test identifies predispositions in appetite regulation and metabolic response mechanisms. When interpreted with qualified healthcare provider guidance, this information may clarify which treatment approaches warrant consideration—whether branded drugs, compounded medications, or combination protocols.

Armed with your genetic insights alongside traditional biomarkers (glucose, lipids, inflammation markers), you and your provider can have a more personalized conversation about weight management. PlexusDx compounded semaglutide, tirzepatide, and combination options are available starting at $129–$325/month if your provider determines peptide therapy is appropriate for your health profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves